Keyphrases
5-fluorouracil (5-FU)
100%
ABCG2
25%
Adjuvant Chemotherapy
25%
ATP Binding Cassette Subfamily B Member 1 (ABCB1)
25%
CES2
25%
Chemotherapy
25%
Colorectal Cancer
50%
Cytochrome P450 3A4 (CYP3A4)
25%
Demographic Data
25%
Differential Response
25%
Disease-free Survival
75%
Drug Pathway
25%
ERCC1
25%
Expression Level
25%
Glutathione S-transferase pi
25%
GSTP1
50%
Histological Subtypes
25%
Irinotecan
25%
Molecular Markers
25%
Mucin
25%
Mucinous
25%
Mucinous Colorectal Cancer
100%
Mucinous Tumor
75%
Multiplex Real-time PCR
25%
New Agents
25%
No Significant Difference
25%
Non-mucinous
100%
Normal mucosa
50%
Overexpressing
25%
Oxaliplatin
50%
Pathway Genes
25%
Patient Matched
25%
Pharmacologic
100%
Quantitative Expression
25%
Recurrent Disease
25%
Total RNA
25%
Tumor
75%
UGT1A1
25%
Worse Prognosis
25%
Medicine and Dentistry
Adjuvant Chemotherapy
20%
Breast Cancer Resistance Protein
20%
Colorectal Cancer
100%
CYP3A4
20%
Disease Free Survival
60%
Fluorouracil
80%
Glutathione Transferase P1
20%
Irinotecan
20%
Molecular Marker
20%
Mucin
20%
Mucinous Tumor
60%
Mucosa
40%
Neoplasm
60%
Oxaliplatin
40%
Recurrent Disease
20%
Reverse Transcription Polymerase Chain Reaction
20%